Drug firms use legal loopholes to safeguard brand names

Drug companies are using legal loopholes to extend patents for their most lucrative brand name products and delay the entry of cheaper generics on to the market, according to a report from the National Institute for Health Care Management.

Intellectual property protections enacted over the past two decades have increased the average patent …